Aire Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.98M Sell
1,710
-14
-0.8% -$16.5K 0.32% 58
2026
Q2
$2.07M Buy
1,724
+10
+0.6% +$10.2K 0.34% 58
2026
Q1
$1.58M Buy
1,714
+21
+1% +$21.3K 0.29% 62
2025
Q4
$1.82M Sell
1,693
-60
-3% -$57.4K 0.33% 58
2025
Q3
$1.34M Sell
1,753
-190
-10% -$141K 0.24% 68
2025
Q2
$1.51M Sell
1,943
-25
-1% -$19.4K 0.29% 63
2025
Q1
$1.63M Sell
1,968
-142
-7% -$118K 0.34% 57
2024
Q4
$1.63M Buy
2,110
+132
+7% +$109K 0.34% 60
2024
Q3
$1.75M Buy
1,978
+108
+6% +$97.1K 0.39% 53
2024
Q2
$1.69M Sell
1,870
-81
-4% -$64.8K 0.39% 57
2024
Q1
$1.52M Buy
1,951
+133
+7% +$94.7K 0.34% 59
2023
Q4
$1.06M Buy
1,818
+10
+0.6% +$5.84K 0.26% 67
2023
Q3
$972K Buy
1,808
+11
+0.6% +$5.67K 0.26% 63
2023
Q2
$843K Sell
1,797
-91
-5% -$38.2K 0.22% 67
2023
Q1
$649K Buy
1,888
+2
+0.1% +$675 0.18% 72
2022
Q4
$690K Sell
1,886
-80
-4% -$28.4K 0.21% 68
2022
Q3
$636K Hold
1,966
– – 0.22% 68
2022
Q2
$640K Buy
+1,966
New +$590K 0.23% 65

Other funds holding LLY

Aire Advisors's LLY Position: Q3 2026 in Review

Aire Advisors reduced its Eli Lilly (LLY) stake by 0.81% in Q3 2026, selling an estimated $16.5K and leaving 1,710 shares worth $1.98M. The position accounts for 0.32% of the portfolio, ranked #58.

Aire Advisors first reported a position in LLY in Q2 2022 and has held it in 18 quarters since. The position peaked at $2.07M in Q2 2026. 2,846 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Aire Advisors held 1,710 shares of Eli Lilly worth $1.98M as of Q3 2026.
  • Aire Advisors sold 14 Eli Lilly shares in Q3 2026, an estimated $16.5K.
  • Eli Lilly made up 0.32% of Aire Advisors's portfolio in Q3 2026, its #58 holding.
  • Aire Advisors first reported a position in Eli Lilly in Q2 2022 and has held it in 18 quarters since.
  • Aire Advisors's Eli Lilly position peaked at $2.07M in Q2 2026.
  • 2,846 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Aire Advisors's 13F filing for Q3 2026, filed 22 Oct 2026.